Milbar Recalls MD Complete Breakout Treatment Due to GMP Deviations
Milbar Laboratories is voluntarily recalling 2,655 bottles of MD Complete Breakout Treatment due to Good Manufacturing Practice deviations.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to GMP deviations, which aligns with the rubric for moderate severity involving low-risk contamination or voluntary precautionary recalls without reported injuries.
Plain-English summary
Milbar Laboratories, Inc. is voluntarily recalling 2,655 bottles of MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles. The product is manufactured by Milbar Laboratories, Inc. and distributed by MD Professional LLC in Minneapolis, MN. The specific lot affected is DX278 with an expiration date of Apr-23.
The recall was initiated because of Good Manufacturing Practice (GMP) deviations. The FDA has classified this recall as Class II, which indicates a situation that may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
The product was distributed throughout the United States, including Puerto Rico, and internationally. Consumers who have this product should stop using it and contact the recalling firm for further instructions.
The recalled product
- Product
- MD Complete Breakout Treatment (Benzoyl Peroxide 4.5%) 1 fl. oz. (30mL) bottles, MD Professional LLC, Minneapolis, MN
- Manufacturer
- Milbar Laboratories, Inc.
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 2,655
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: DX278
- Exp. Date Apr-23
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 14 recalled by Milbar Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Milbar Laboratories, Inc.
See all →- ModerateMilbar Recalls Malin+Goetz SPF 30 Face Moisturizer Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Clear Skin Salicylic Acid Tubes Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Willa Pore Perfector Pads Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls DCL SA Scalp Therapy Shampoo Due to GMP Deviations
FDA (Drugs) · 2020-11-25
- ModerateMilbar Recalls Malin + Goetz Salicylic Gel Due to GMP Deviations
FDA (Drugs) · 2020-11-25
Same hazard · gmp deviation
See all →- HighPrazosin hydrochloride tablets recalled over nitrosamine impurity above limits
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride further lots recalled over nitrosamine impurity levels
FDA (Drugs) · 2026-04-08
- HighPrazosin hydrochloride 100-count bottles recalled over nitrosamine impurity
FDA (Drugs) · 2026-04-08
- ModerateFirst Aid Only hand sanitizing wipes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11
- ModerateFirst Aid Only BZK antiseptic towelettes recalled over manufacturing deviations
FDA (Drugs) · 2026-03-11